Metrika
This article was originally published in The Gray Sheet
Executive Summary
Commercial availability of single-use A1cNow diabetes monitor for measuring gold standard indicator hemoglobin A1c (HbA1c) is announced Feb. 19. The disposable, pager-sized, finger-stick device provides results in eight minutes, allowing prescription use by diabetes patients between physician visits. Launch of the CLIA-waived test, 510(k)-cleared in July 2000 for in-office use and in September 2000 for prescription home-use, was supported by a $26 mil. mezzanine round of financing completed in April 2001 (1"The Gray Sheet" April 23, 2001, In Brief)...